Enable Accessibility
Enable Accessibility
Better Health,
Brighter Future
Newsroom
Careers
Investors
United States
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Takeda in the U.S.
Worldwide Offices
Executive Leadership
Corporate Philosophy
Takeda Pricing Philosophy
Contact Us
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Our Pipeline
Therapeutic Areas
Patient Services & Assistance
U.S. Product List
Independent Medical Education Grants
Our Stories
Our Stories
A selection of stories related to Innovation, Caring and Heritage
Learn more
How Our Los Angeles Site Pursues Energy Independency and Helps Takeda Become a Carbon-zero Operation
Caring
Answering the Call How Takeda Cares
Advancing Health Equity Built on Trust
Takeda Redoubles DEI Efforts With Insight Action
How Takeda is thinking about value-based arrangements with payers
Building trust between the pharma industry and Black and Brown communities
Strengthening the communities where we live and work
Heritage
Corporate Responsibility
Purpose-led Sustainability
Sustainability underpins all we do at Takeda to help solve key societal challenges and create value for society.
Learn more
Patients
Patient Services and Assistance
Diversity, Equity & Inclusion in R&D
People
Diversity, Equity & Inclusion
Commitment to Community
Careers
Planet
Ethics and Compliance
Statements & Disclosures
HOME
Newsroom
US News Releases
Share:
Newsroom
US News Releases
Statements
NATPARA Updates
Global News Releases
US News Releases
Enter
All
Last 12 months
2022
2021
2020
2019
2018
2017
2016
October 2020
October 27, 2020
10/27/2020
Takeda to Present Rare Bleeding Disorders Research at Thrombosis & Hemostasis Summit of North America (THSNA) 2020
August 2020
August 10, 2020
8/10/2020
National Hemophilia Foundation and Takeda Partner with Alex Borstein to Raise Awareness of von Willebrand Disease
August 1, 2020
8/1/2020
Takeda to Present Rare Bleeding Disorders Research Highlighting Need for Real-World Evidence at NHF Bleeding Disorders Conference 2020
April 2020
April 23, 2020
4/23/2020
ProThera Biologics and Takeda Enter Global Licensing Agreement
April 16, 2020
4/16/2020
USBU COVID-19 Supply Statement
March 2020
March 25, 2020
3/25/2020
Supporting Our Communities During the COVID-19 Outbreak
March 12, 2020
3/12/2020
Supporting Our Healthcare Providers During COVID-19
March 6, 2020
3/6/2020
Update on US Recall of Two Lots of VONVENDI® [von Willebrand factor (recombinant)]
1
2
3
4
5
TOP
Close
